| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/04/2013 | WO1999012552A8 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS |
| 07/04/2013 | US20130174288 Antibodies for the treatment of hiv |
| 07/04/2013 | US20130172847 Compositions for Providing Vitamin D Year Round and Uses Thereof |
| 07/04/2013 | US20130172656 Novel use of armillaridin for treating cancer |
| 07/04/2013 | US20130172528 Dalbavancin compositions for treatment of bacterial infections |
| 07/04/2013 | US20130172426 Fat-reducing agent |
| 07/04/2013 | US20130172425 Compositions and methods for treating hoof diseases |
| 07/04/2013 | US20130172423 Vitamin containing product |
| 07/04/2013 | US20130172421 Use of kukoamine a and kukoamine b |
| 07/04/2013 | US20130172418 Pharmaceutical composition comprising n-acetyl-l-cysteine or its derivatives for treating anxiety disorder |
| 07/04/2013 | US20130172417 Medium chain peroxycarboxylic acid compositions |
| 07/04/2013 | US20130172416 Compositions comprising acidic extracts of mastic gum |
| 07/04/2013 | US20130172414 Pharmaceutical composition comprising levocarnitine and dobesilate |
| 07/04/2013 | US20130172413 Stable pharmaceutical composition and methods of using same |
| 07/04/2013 | US20130172412 Methods for Improving Cognitive Function and Decreasing Heart Rate |
| 07/04/2013 | US20130172411 Stable pharmaceutical compositions comprising fesoterodine |
| 07/04/2013 | US20130172407 Inhibition of Cancer Cell Proliferation Using Oleoylethanolamide |
| 07/04/2013 | US20130172401 Composition for regenerating normal tissue from fibrotic tissue |
| 07/04/2013 | US20130172398 Combined Acetylcholinesterase Inhibitor and Quaternary Ammonium Antimuscarinic Therapy to Alter Progression of Cognitive Diseases |
| 07/04/2013 | US20130172397 Use of inhibitors of porphobilinogen deaminase in the treatment of congenital erythropoietic porphyria |
| 07/04/2013 | US20130172395 Compounds for anti-fungal treatment |
| 07/04/2013 | US20130172394 Use of pramipexole to treat amyotrophic lateral sclerosis |
| 07/04/2013 | US20130172391 Pharmaceutical compositions |
| 07/04/2013 | US20130172387 Method and composition for prolonging analgesic effect of local anesthetic |
| 07/04/2013 | US20130172386 5-ht2b receptor antagonists |
| 07/04/2013 | US20130172385 Anthelmintics for preventing parasitic infections in humans and animals |
| 07/04/2013 | US20130172383 Treatment of fibrosing disorders |
| 07/04/2013 | US20130172382 Abuse-resistant controlled-release opioid dosage form |
| 07/04/2013 | US20130172381 Oral dosage forms for oxygen-containing active agents and oxyl-containing polymer |
| 07/04/2013 | US20130172380 Method of restoring the incretin effect |
| 07/04/2013 | US20130172379 Combined Acetylcholinesterase Inhibitor and Quaternary Ammonium Antimuscarinic Therapy to Alter Progression of Cognitive Diseases |
| 07/04/2013 | US20130172378 Combination of BRAF and VEGF Inhibitors |
| 07/04/2013 | US20130172377 Administration of dipeptidyl peptidase inhibitors |
| 07/04/2013 | US20130172376 Solid dosage forms of (s)-ethyl 2-amino-3-(4-(2-amino-6-((r)-1-(4-chloro-2-(3-methyl-1h-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate |
| 07/04/2013 | US20130172375 Pharmaceutical composition |
| 07/04/2013 | US20130172373 Quinazoline compounds |
| 07/04/2013 | US20130172372 Ring-fused 4-aminopyrimidines and use thereof as stimulators of soluable guanylate cyclases |
| 07/04/2013 | US20130172371 Methods of Treating Cancer Using Pyridopyrimidinone Inhibitors of PI3K and mTOR in Combination with Autophagy Inhibitors |
| 07/04/2013 | US20130172370 Pharmaceutical composition for use in the treatment of glaucoma |
| 07/04/2013 | US20130172368 Methods for Treating Hyperuricemia in Patients with Gout Using Halofenate or Halogenic Acid and A Second Urate-Lowering Agent |
| 07/04/2013 | US20130172362 Imidazothiazole Derivatives Having Proline Ring Structure |
| 07/04/2013 | US20130172360 Derivatives of azaindazole or diazaindazole type as medicament |
| 07/04/2013 | US20130172359 Compounds, Formulations, and Methods for Treating or Preventing Inflammatory Skin Disorders |
| 07/04/2013 | US20130172358 Compounds, Formulations, and Methods for Treating or Preventing Inflammatory Skin Disorders |
| 07/04/2013 | US20130172357 Compositions and Methods for Treatment of Glaucoma |
| 07/04/2013 | US20130172356 Combination of egcg or methylated egcg and a pde inhibitor |
| 07/04/2013 | US20130172351 Dihydropyrazoles |
| 07/04/2013 | US20130172349 Inhibitors of phosphatidylinositol 3-kinase |
| 07/04/2013 | US20130172344 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
| 07/04/2013 | US20130172337 Imidazo[4,5-c]quinolines as DNA-PK inhibitors |
| 07/04/2013 | US20130172336 4-anilinofuro[2,3-b]quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same |
| 07/04/2013 | US20130172334 Trpv1 antagonists |
| 07/04/2013 | US20130172333 Formulation and dosing of hsp90 inhibitory compounds |
| 07/04/2013 | US20130172332 Compositions and methods for bone formation and modeling |
| 07/04/2013 | US20130172331 Novel oxazine derivatives and their use in the treatment of disease |
| 07/04/2013 | US20130172330 Chemokine Receptor Modulators |
| 07/04/2013 | US20130172327 Substituted n- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin c |
| 07/04/2013 | US20130172325 Novel homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof |
| 07/04/2013 | US20130172324 Method for treating cardiovascular diseases using rho kinase inhibitor compounds |
| 07/04/2013 | US20130172322 Benzazepine derivatives useful for treatment of 5ht2c receptor associated diseases |
| 07/04/2013 | US20130172321 Compositions Comprising Nicotinic Agonists and Methods of Using Same |
| 07/04/2013 | US20130172314 PYRAZOLO[3,4-d]PYRIMIDINE AND PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS AS KINASE INHIBITORS |
| 07/04/2013 | US20130172313 Carbapenem Antibacterials with Gram-Negative Activity |
| 07/04/2013 | US20130172311 Substituted heterocyclyl benzyl pyrazoles, and use thereof |
| 07/04/2013 | US20130172310 Benzamides and related inhibitors of factor xa |
| 07/04/2013 | US20130172308 Antimicrobial agents |
| 07/04/2013 | US20130172307 5a-ANDROSTANE (ALKYL)-3b, 5, 6b-TRIOL INJECTION AND PREPARATION METHOD THEREFOR |
| 07/04/2013 | US20130172306 Use of an estrogen derivative for the manufacture of pharmaceutical compositions useful for the treatment and/or prevention of psychiatric diseases and for the treatment and prevention of said diseases |
| 07/04/2013 | US20130172305 Acute Treatment of Social Phobia |
| 07/04/2013 | US20130172304 Pharmaceutical Compositions Comprising Flibanserin and a Further Agent in the Treatment of Sexual Disorders |
| 07/04/2013 | US20130172303 Roflumilast compositions for the treatment of copd |
| 07/04/2013 | US20130172302 Quinuclidine esters of 1-azaheterocyclylacetic acid as antimuscarinic agents, process for their preparation and medicinal compositions thereof |
| 07/04/2013 | US20130172301 Biphenyl compounds useful as muscarinic receptor antagonists |
| 07/04/2013 | US20130172300 New hormonal composition and its use |
| 07/04/2013 | US20130172299 Combination Therapy for Treatment of Bone and Mineral Disorders for Patients with Impaired Renal Function |
| 07/04/2013 | US20130172298 Okadaella Gastrococcus and Cancer |
| 07/04/2013 | US20130172297 Treatment of Autoimmune Diseases |
| 07/04/2013 | US20130172296 Method of activation of oxazaphosphorines |
| 07/04/2013 | US20130172295 Process for preparation of hiv protease inhibitors |
| 07/04/2013 | US20130172294 Treatment with VB-201 |
| 07/04/2013 | US20130172293 Drug against central nervous system inflammation |
| 07/04/2013 | US20130172287 Agent for treatment of dry eye characterized by combining p2y2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof |
| 07/04/2013 | US20130172286 Functional Food Supplement Intended, In Particular, For Nutrition And For Prevention And Improvement of Neurological Alterations, Neurodegenerative Alterations Or Cognitive Disorders |
| 07/04/2013 | US20130172284 Use of 1-beta-d-ribofuranosyl-1h-1,2,4-triazole-3-carboxamide for the treatment of infectious salmon anemia |
| 07/04/2013 | US20130172283 Lyophilized formulation of pectin-adriamycin conjugate and preparation method thereof |
| 07/04/2013 | US20130172282 Method of treating herpes virus infection using macrocyclic lactone compound |
| 07/04/2013 | US20130172281 Compositions for treating heartworm infestation |
| 07/04/2013 | US20130172279 Composition for topical treatment of mixed vaginal infections |
| 07/04/2013 | US20130172277 Pharmaceutical combination |
| 07/04/2013 | US20130172271 Pharmaceutical Spray Drying |
| 07/04/2013 | US20130172260 Prevention of indwelling device related infection: composition and methods |
| 07/04/2013 | US20130172256 Method of treating diabetes-related impaired wound healing |
| 07/04/2013 | US20130172255 Compositions and methods for treating joints |
| 07/04/2013 | US20130172249 Purine compounds as prodrugs of a2b adenosine receptor antagonists, their process and medicinal applications |
| 07/04/2013 | US20130172248 3-[4-(phenylaminooxalylamino)phenyl]hex-4-ynoic acids, process for preparation thereof and use thereof as a medicament |
| 07/04/2013 | US20130172244 Subcutaneous therapeutic use of dpp-4 inhibitor |
| 07/04/2013 | US20130172240 Methods for treating hcv |
| 07/04/2013 | US20130172239 Solid compositions |
| 07/04/2013 | US20130172238 Method for selective oligonucleotide modification |
| 07/04/2013 | US20130171273 Method of treating impaired wound healing in diabetics |